Breast cancerOvarian cancerLung cancerGastric cancer
Breast cancerLiver cancerPan-cancer
2. Select dataset:
METABRIC: long follow-up (median: 94 months), average characteristics (78% ER positive, 12% HER2 positive), treatment data available for this dataset only!
TCGA: very short follow-up (median only 25 months), no grade.
GSE40267: almost exclusively ER negative patients (92%).
GSE19783: nodal status not available, 38% ER negative, high proportion of HER2 positive patients (18%).
n = number of patients with available clinical data
Please note: the generated p value does not include correction for multiple hypothesis testing by default.
Please kindly cite our paper to support further development: Gyorffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q, Szallasi Z. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1809 patients, Breast Cancer Res Treatment, 2010 Oct;123(3):725-31.
KMplot.com Copyright © 2009-2020 | Contact